Editors' ChoiceCancer

Antiangiogenic cancer drug drives lymphangiogenic metastasis

+ See all authors and affiliations

Science Translational Medicine  08 Feb 2017:
Vol. 9, Issue 376, eaam6060
DOI: 10.1126/scitranslmed.aam6060

You are currently viewing the abstract.

View Full Text

Abstract

Tumor blood vessel–destroying cancer drug induces development of tumor lymphatics that contribute to treatment failure.

View Full Text